INCYTE CORPORATION Property, Plant and Equipment
INCYTE CORPORATION (INCY) had Property, Plant and Equipment of $720.17 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-04-28
- 2026-03-31: Property, Plant and Equipment, Net $720.17M.
- 2025-12-31: Property, Plant and Equipment, Net $730.88M.
- 2025-09-30: Property, Plant and Equipment, Net $798.63M.
- 2025-06-30: Property, Plant and Equipment, Net $798.54M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-03-31 | $720.17M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $730.88M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $798.63M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $798.54M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $765.36M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $763.41M 10-K · filed 2026-02-10 |
| 2024-09-30 | $773.10M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $762.01M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $720.00M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $751.51M 10-K · filed 2025-02-10 |
| 2023-09-30 | $733.05M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $749.35M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $741.70M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $739.31M 10-K · filed 2024-02-13 |
| 2022-09-30 | $715.73M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $721.33M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $729.22M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $723.92M 10-K · filed 2023-02-07 |
| 2021-09-30 | $686.72M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $661.36M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $594.67M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $559.63M 10-K · filed 2022-02-08 |
| 2020-09-30 | $498.33M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $453.78M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $410.03M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $377.57M 10-K · filed 2021-02-09 |
| 2019-09-30 | $347.25M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $339.12M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $338.33M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $319.75M 10-K · filed 2020-02-13 |
| 2018-09-30 | $300.77M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $267.59M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $264.61M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $259.76M 10-K · filed 2019-02-14 |
| 2017-09-30 | $246.82M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $218.88M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $193.21M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $167.68M 10-K · filed 2018-02-15 |
| 2016-09-30 | $151.94M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $138.51M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $92.62M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $86.01M 10-K · filed 2017-02-14 |
| 2015-09-30 | $83.19M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $81.60M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $80.67M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $81.79M 10-K · filed 2016-02-12 |
| 2014-09-30 | $75.26M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $55.61M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $38.65M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $26.85M 10-K · filed 2015-02-17 |
| 2013-09-30 | $6.20M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $6.24M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $6.49M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $6.35M 10-K · filed 2014-02-21 |
| 2012-09-30 | $6.17M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $6.51M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $6.23M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $6.43M 10-K · filed 2013-02-21 |
| 2011-09-30 | $6.08M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $5.50M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $4.93M 10-Q · filed 2011-05-03 |
| 2010-12-31 | $4.80M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |